AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2011
Feb 7, 2011
30339_dirs_2011-02-07_51b837fb-123b-4277-a8f3-9a5ecefed0f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-04
Reporting Person: LUZZI RICHARD D (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-04 | Common Stock | F | 510.0000 | — | Disposed | 27509.0411 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 459.1694 | Indirect |
| Common Stock | 14926.9750 | Indirect |
Footnotes
F1: Change in the amount of securities beneficially owned is due to change of form of ownership from indirect to direct due to the distribution of vested deferred stock units credited to the participant's account under the terms of the Nonqualified Deferred Compensation Plan for Designated Employees. These deferred stock units were distributed in the form of unrestricted whole shares of stock and are now held directly by the participant.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12